Release
2025/07/17
OSAKA, Japan, July 17, 2025 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.) announced that the disposal of treasury shares as restricted stock compensation plan, decided at the meeting of its Board of Directors held on June 18, 2025, was completed today as follows. For details, please refer to the release on June 18, 2025.
Outline of the Disposal
(１) Disposal date |
July 17, 2025 |
(２) Class and number of shares to be disposed |
200,400 shares of common stock of Shionogi |
(３) Disposal price |
\2,496.5 per share* |
(４) Total value of shares to be disposed |
\500,298,600 |
(５) Allottees, number of them, and number of shares to be disposed |
Directors (excluding Directors who are Audit and Supervisory Committee members and Outside Directors): 2 persons 58,500 shares Corporate officers (excluding those who concurrently serve as Directors): 15 persons 101,700 shares Vice Presidents: 55 persons 40,200 shares |
* The closing price for the common shares of the company on the Prime Section of the Tokyo Stock Exchange
on June 17, 2025 (the business day prior to the day of resolution at the meeting of the Board of Directors)
Forward-Looking Statements
This announcement contains forward-looking statements. These statements are based on expectations in light of the information currently available, assumptions that are subject to risks and uncertainties which could cause actual results to differ materially from these statements. Risks and uncertainties include general domestic and international economic conditions such as general industry and market conditions, and changes of interest rate and currency exchange rate. These risks and uncertainties particularly apply with respect to product-related forward-looking statements. Product risks and uncertainties include, but are not limited to, completion and discontinuation of clinical trials; obtaining regulatory approvals; claims and concerns about product safety and efficacy; technological advances; adverse outcome of important litigation; domestic and foreign healthcare reforms and changes of laws and regulations. Also for existing products, there are manufacturing and marketing risks, which include, but are not limited to, inability to build production capacity to meet demand, lack of availability of raw materials and entry of competitive products. The company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
For Further Information, Contact:
SHIONOGI Website Inquiry Form: https://www.shionogi.com/global/en/contact.html